Argentina received more than 81.1 million doses of vaccines since the beginning of the strategic plan for immunization against the coronavirus that the national government is carrying out throughout the country, according to official sources.
The country reached the figure of 81,139,985 vaccines, after the arrival this morning at 7.21 of the flight AA931 of the American Airlines company, from Miami, with a new shipment of 747,630 doses from the Pfizer laboratory, destined for adolescents.
Meanwhile, yesterday afternoon another shipment had arrived, with 877,500 doses from the same laboratory, which will be destined for the population between 12 and 18 years of age throughout the country.
Of the total of 81,139,985 vaccines, 14,183,210 correspond to Sputnik V (10,125,655 from component 1, and 4,057,555 from component 2), and 4,759,625 to Sputnik V produced in Argentina by Laboratorio Richmond (1,179,625 from first component, and 3,580,000 of the second).
24,265,400 doses correspond to the AstraZeneca firm (580,000 from Covishield; 1,944,000 received by the COVAX mechanism, 18,989,000 from AstraZeneca and Oxford whose active ingredient was produced in Argentina; and 2,202,800 donated by Spain and 549,600 by Canada ).
Meanwhile, 30,000,000 correspond to the Sinopharm laboratory, 3,500,000 to Moderna donated by the United States, 600,000 to Cansino and 3,831,750 to Pfizer.
Between today and tomorrow, some 625 thousand doses of component 2 of Sputnik V will be distributed throughout the country, with the aim of continuing to advance in the application of complete vaccination schedules.
According to the criteria established by the sanitary portfolio based on the population of each district, the province of Buenos Aires will have 241,875 doses; 41,625 to the Autonomous City of Buenos Aires; to Catamarca 5,625; to Chaco 16,875; to Chubut 9,000; to Córdoba 51,750; to Corrientes 15,750.
Meanwhile, Entre Ríos corresponds to 19,125; Formosa 8,125; Jujuy 10,375; to La Pampa 4,750; to La Rioja 5,625; to Mendoza 27,500; to Missions 17,125; to Neuquén 9,000; to Río Negro 10,125; to Salta 19,375; to San Juan 11,250; to San Luis 6,750; to Santa Cruz 5,625; to Santa Fe 48,375; to Santiago del Estero 13,500; to Tierra del Fuego 2,250 and to Tucumán 23,625.
Yesterday, almost a million AstraZeneca vaccines donated by Spain through the Covax mechanism had already arrived in the country, this being the second shipment arrived from the Iberian country through the global mechanism for equitable access to vaccines and the third batch of vaccines against the SARS-CoV-2 virus donated to the country by the Spanish Government.
The shipment with 960,400 doses arrived at the Ezeiza International Airport at 6:00 p.m. on flight UC1102 of the LAN Cargo company.
Last August, Spain began donating 7.5 million doses to Latin American and Caribbean countries, out of the total of 22.5 million that it will donate globally through the Covax system and other multilateral mechanisms.
In this framework, Argentina received 400,000 vaccines from AstraZeneca on August 22, and another 842,400 units on September 23, so this shipment totals 2,202,800 units provided to the country by the Spanish Government.
This morning, the pediatrician and director of the Hospital Garrahan Oscar Trotta affirmed today that the vaccination of children, which began yesterday throughout the country “protects the adults in their environment and allows them to reach herd immunity.”
The specialist considered that the immunization campaign against the coronavirus for children between 3 and 11 years of age “gives protection not only to children, to prevent that vulnerable population from being unprotected, but also to adults who are part of their environments,” like their families, caregivers and teachers. “
“We must try to have the largest number of immunized inhabitants to be able to corner the virus, if Argentina wants to achieve herd immunity, it has to incorporate those 6,000,000 boys,” he added.
More than 100,000 boys between 3 and 11 years old received the first dose against COVID-19
The doctor specified that “if we do not vaccinate children, the virus has a place to infect and replicate, it can genetically mutate and become more aggressive, generating a new cycle of pandemic.”
In turn, he emphasized that the studies carried out in the United Kingdom, Canada and Israel “found that the centers of concentration of the Delta variant occurred in schools.”
He assured, on the other hand, that “the Sinopharm vaccine (which is authorized by Anmat to inoculate boys and girls) is safe and effective,” and explained that it is made on a technological platform that is virus-inactivated, which ” We already know in pediatrics because we already use it in other official calendar vaccines, such as polio, hepatitis, and flu. ” (Télam)